½ÃÀ庸°í¼­
»óǰÄÚµå
1601138

¼¼°èÀÇ ¾È°ú¿ë ºñ½ºÄÚ½º ¼ö¼ú ±â±â ½ÃÀå : Á¦Ç°, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Ophthalmic Viscosurgical Devices Market by Product (Cohesive, Combined, Dispersive), Application (Cataract Surgery, Glaucoma Surgery, Keratoplasty), End User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 186 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¾È°ú¿ë ºñ½ºÄÚ½º ¼ö¼ú ±â±â ½ÃÀåÀº 2023³â¿¡ 6¾ï 4,833¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 7¾ï 286¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 8.81%·Î ¼ºÀåÇϰí, 2030³â¿¡´Â 11¾ï 7,129 ¸¸¹Ì ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¾È°ú¿ë ºñ½ºÄÚ½º ¼ö¼ú ±â±â(OVD)´Â ¾È°ú¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ´ã´çÇϰí ÀÖÀ¸¸ç, ÁÖ·Î ¹é³»Àå ¹× ±âŸ ¾È±¸ ¼ö¼ú¿¡ »ç¿ëµÇ¸ç Àü¹æ ½Éµµ À¯Áö, °¢¸· ³»ÇÇ ¼¼Æ÷ º¸È£, À¯¸®Ã¼¸é ¾ÈÁ¤È­¸¦ µµ¸ðÇÕ´Ï´Ù. ¼¼°èÀÇ ³ëÈ­·Î ¹é³»Àå°ú ±×¿Í °ü·ÃµÈ ¾È°ú ÁúȯÀÇ À¯º´·üÀÌ ³ô¾ÆÁö´Â °¡¿îµ¥ OVDÀÇ Çʿ伺ÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÌ ÀåÄ¡´Â ¼ö¼úÀ» ¿ëÀÌÇϰÔÇÏ°í ¼ö¼ú ÈÄ ÇÕº´ÁõÀ» ÃÖ¼ÒÈ­Çϸ鼭 Á¤È®¼º°ú ¾ÈÀü¼ºÀ» º¸ÀåÇÏ´Â µ¥ Àû¿ëµË´Ï´Ù. ÃÖÁ¾ ¿ëµµ¿¡´Â º´¿ø, ¾È°ú Ŭ¸®´Ð, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC) µîÀÌ Æ÷ÇԵǾî ÀÖÀ¸¸ç, ¼±Áø ¼ö¼ú ÀýÂ÷ ¹× Àåºñ¸¦ ¼±ÅÃÇÏ´Â °æÇâÀÌ °­ÇØÁö°í ÀÖ½À´Ï´Ù. ½ÃÀå °³Ã´Àº ³·Àº ħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí, ¾È°ú Á¦Ç°ÀÇ ±â¼ú Áøº¸, ½ÅÈï±¹ ½ÃÀå¿¡¼­ÀÇ °Ë¾ÈÀÇ¿Í ¾È°ú ÀÇ»ç Áõ°¡ µîÀÇ ¿äÀο¡ ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Á¤ºÎÀÇ Áö¿ø°ú ÀÇ·á º¸ÇèÀº ¾È°ú ÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ ±¤¹üÀ§ÇÑ ¾×¼¼½º¿Í Àú·ÅÇÑ °¡°ÝÀ» °¡´ÉÇϰÔÇÏ°í ½ÃÀå Àü¸ÁÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç°ú ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ¹Ì°³Ã´ ½ÃÀå¿¡´Â »õ·Î¿î ºñÁî´Ï½º ±âȸ°¡ Àáµé¾î ÀÖ¾î ¾È°ú ÀÇ·á¿¡ ´ëÇÑ ÅõÀÚ¿Í °è¸ù Ä·ÆäÀÎÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ±â¾÷Àº ÆÇ¸Å¸ÁÀ» È®´ëÇϰí ÇöÁö ÀÇ·á±â°ü°ú Á¦ÈÞÇÔÀ¸·Î½á Å« ½ÃÀå Á¡À¯À²À» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ÀÌ ½ÃÀåÀº ¼ö¼ú°ú ±â±¸ÀÇ ºñ¿ëÀÌ ³ô°í, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎÀÌ ¾î·Á¿öÁö°í, OVDÀÇ ºÎÀûÀýÇÑ »ç¿ëÀ¸·Î ÀÎÇÑ ÇÕº´ÁõÀÇ °¡´É¼ºÀÌ ÀÖ´Ù´Â µîÀÇ Á¦¾à¿¡ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. ±â¼ú Çõ½ÅÀº ºñ¿ë È¿°úÀûÀÌ°í »ýºÐÇØ¼ºÀÌ ÀÖ°í »ýüÀûÇÕ¼ºÀÌ ÀÖ´Â OVDÀÇ °³¹ß¿¡ ÃÊÁ¡À» ¸ÂÃß¾î ȯÀÚÀÇ °á°ú¿Í ÀåºñÀÇ È¿À²¼ºÀ» ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¸ÂÃãÇü ÀÇ·á¿Í µðÁöÅÐ °Ç°­ ±â¼úÀÇ ÅëÇÕ¿¡ ´ëÇÑ Á¶»ç¸¦ ÅëÇØ »õ·Î¿î ¼ºÀå ±æÀ» ¿­ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº Ä¡¿­ÇÑ °æÀïÀ» Ư¡À¸·Î Çϸç ÁÖ¿ä ±â¾÷µéÀº ºñ°è¸¦ À¯ÁöÇϱâ À§ÇØ Àü·«Àû M&A, Á¦Ç° Çõ½Å, Áö¿ª È®´ë¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ÀÌ ¶§¹®¿¡ ±â¾÷Àº Àü·«Àû ÆÄÆ®³Ê½Ê, ¿¬±¸°³¹ß ÅõÀÚ, ±â¼úÀû Áøº¸¸¦ Áß½ÃÇØ¾ß ÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ (2023³â) 6¾ï 4,833¸¸ ´Þ·¯
¿¹Ãø³â(2024³â) 7¾ï286¸¸ ´Þ·¯
¿¹Ãø³â(2030³â) 11¾ï 7,129¸¸ ´Þ·¯
CAGR(%) 8.81%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ¾È°ú¿ë ºñ½ºÄÚ½º ¼ö¼ú ±â±â ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

¾È°ú¿ë ºñ½ºÄÚ½º ¼ö¼ú ±â±â ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. °áÁ¤ÀÇ Á¤±³È­¿Í »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñ ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖÀ¸¸ç ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ´õ ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¾È°ú¿Í ¾ÈÁúȯ ȯÀÚ Áõ°¡
    • ¼³ºñ°¡ °®Ãß¾îÁø ÀÇ·á ÀÎÇÁ¶óÀÇ ÀÌ¿ë °¡´É¼º°ú ÀǾàǰ Àΰ¡¼ö Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • Àúħ½À¼º°ú ºñħ½À¼º Ä¡·á ¿É¼ÇÀÇ ÀÌ¿ë °¡´É¼º
  • ½ÃÀå ±âȸ
    • »õ·Î¿î À¯ÇüÀÇ ¾È°ú¿ë ºñ½ºÄÚ½º ¼ö¼ú ±â±âÀÇ Ã¤¿ë
    • ¾È°ú ¼ö¼ú¿ë Á¡ÂøÁ¦ÀÇ Áö¼ÓÀûÀÎ ÀÓ»óÀû °ËÅä
  • ½ÃÀåÀÇ °úÁ¦
    • ¾È°ú ¼ö¼úÀ» À§ÇÑ ¼÷·ÃµÈ Àü¹®°¡ÀÇ Á¦ÇÑµÈ °¡¿ë¼º

Porter's Five Force : ¾È°ú¿ë ºñ½ºÄÚ½º ¼ö¼ú ±â±â ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Force Framework´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ´ç½ÅÀº ´õ °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¾È°ú¿ë ºñ½ºÄÚ½º ¼ö¼ú ±â±â ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¾È°ú¿ë ºñ½ºÄÚ½º ¼ö¼ú ±â±â ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇϴµ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸ ±â¾÷Àº PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¾ÕÀ» ³»´Ùº¸°í Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡µÇ¾î ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ¾È°ú¿ë ºñ½ºÄÚ½º ¼ö¼ú ±â±â ½ÃÀå¿¡¼­ °æÀï ±¸µµ ÆÄ¾Ç

¾È°ú¿ë ºñ½ºÄÚ½º ¼ö¼ú ±â±â ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀå ÁýÁß, ¼¼ºÐÈ­ ¹× ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í °ø±Þ¾÷ü´Â °æÀïÀÌ Ä¡¿­ ÇØÁü¿¡ µû¶ó ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÕ´Ï´Ù. Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º: ¾È°ú¿ë ºñ½ºÄÚ½º ¼ö¼ú ±â±â ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¾È°ú¿ë ºñ½ºÄÚ½º ¼ö¼ú ±â±â ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Æò°¡¸¦ ÅëÇØ ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â Á¾ÇÕÀûÀÎ ½ÃÀå ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: »ê¾÷ ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅ͸¦ Æ÷ÇÔÇÑ ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÎ¹®¿¡¼­ÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» ¼³¸íÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, »ê¾÷ÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡µµ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¾È°ú Áúȯ Áõ°¡
      • ¼³ºñ°¡ °®Ãß¾îÁø ÀÇ·á ÀÎÇÁ¶óÀÇ Á¤ºñ¿Í ÀǾàǰ ½ÂÀμö Áõ°¡
    • ¾ïÁ¦¿äÀÎ
      • ³·Àº ħ½À ¹× ºñħ½À Ä¡·á ¿É¼ÇÀÇ °¡¿ë¼º
    • ±âȸ
      • »õ·Î¿î À¯ÇüÀÇ ¾È°ú¿ë ºñ½ºÄÚ½º ¼ö¼ú ±â±âÀÇ Ã¤¿ë
      • ¾È°ú Á¡¸· ¼ö¼ú¿ë Á¢ÂøÁ¦ÀÇ ÀÓ»óÀû °ËÅäÀÇ °è¼Ó
    • °úÁ¦
      • ¾È°ú ¼ö¼úÀÇ ¼÷·ÃµÈ Àü¹®°¡ÀÇ ºÎÁ·
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
    • Á¦Ç°: ´Ù¿ëµµ¼º°ú ¼ö¼úÀÇ ¾ÈÀü¼º¿¡ ÀÇÇØ ÀÀÁý¼º°ú ºÐ»ê¼º OVDÀÇ ÀαⰡ ³ô¾ÆÁö°í ÀÖ´Ù
    • ¿ëµµ: ȯÀÚÀÇ ¾ÈÀüÀ» È®º¸Çϸ鼭 ¼±¸íÇÑ ½Ã°¢À» Á¦°øÇÏ´Â ¹é³»Àå ¼ö¼ú°ú °¢¸· ÀÌ½Ä ¼ö¼ú¿¡ À־ÀÇ OVDÀÇ »ç¿ëÀÌ Áõ°¡
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ
  • °í°´ ¸ÂÃãÇü

Á¦6Àå ¾È°ú¿ë ºñ½ºÄÚ½º ¼ö¼ú ±â±â ½ÃÀå : Á¦Ç°º°

  • ¼Ò°³
  • ÀÀÁý
  • Á¶ÇÕ
  • ºÐ»ê

Á¦7Àå ¾È°ú¿ë ºñ½ºÄÚ½º ¼ö¼ú ±â±â ½ÃÀå : ¿ëµµº°

  • ¼Ò°³
  • ¹é³»Àå ¼ö¼ú
  • ³ì³»Àå ¼ö¼ú
  • °¢¸· À̽Ä

Á¦8Àå ¾È°ú¿ë ºñ½ºÄÚ½º ¼ö¼ú ±â±â ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¼Ò°³
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • ¾È°ú Àü¹® Ŭ¸®´Ð
  • º´¿ø

Á¦9Àå ¾Æ¸Þ¸®Ä« ¾È°ú¿ë ºñ½ºÄÚ½º ¼ö¼ú ±â±â ½ÃÀå

  • ¼Ò°³
  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ¾È°ú¿ë ºñ½ºÄÚ½º ¼ö¼ú ±â±â ½ÃÀå

  • ¼Ò°³
  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ¾È°ú¿ë ºñ½ºÄÚ½º ¼ö¼ú ±â±â ½ÃÀå

  • ¼Ò°³
  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023³â
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
    • Coherus°¡ ¾È°ú »ç¾÷À» Sandoz¿¡ ¸Å°¢
    • Rayner°¡ Sophi Àμö¸¦ ¹ßÇ¥
    • Bausch LombÀÌ ¹Ì±¹¿¡¼­ ½ÅÁ¦Ç° ¾È°ú¿ë ºñ½ºÄÚ½º ¼ö¼ú ±â±â¸¦ ¹ß¸Å

±â¾÷ ¸ñ·Ï

  • Bausch & Lomb Incorporated
  • Amring Pharmaceuticals Inc.
  • Advin Health Care
  • SERVImed Industrial SpA
  • Rayner Group
  • Johnson & Johnson Services, Inc.
  • Lifecore Biomedical, Inc.
  • Bohus BioTech AB
  • Ophtechnics Unlimited
  • Fidia Farmaceutici SpA
  • Alcon Inc.
  • Precision Lens
  • Truviz Ophthalmic
  • Ildong Hyaltech Co., Ltd.
  • Bloomage BIoTechnology Corporation Limited
  • Henan Universe Intraocular Lens Research and Manufacture Co., Ltd.
  • ALBOMED GmbH
  • LG Chem Life Sciences
  • Beaver-Visitec International, Inc.
  • Kewpie Corporation
  • CIMA Technology, Inc.
  • Carl Zeiss AG
  • Advanced BioMatrix
  • Maxigen BIoTech Inc.
  • Contipro as
JHS 24.12.12

The Ophthalmic Viscosurgical Devices Market was valued at USD 648.33 million in 2023, expected to reach USD 702.86 million in 2024, and is projected to grow at a CAGR of 8.81%, to USD 1,171.29 million by 2030.

Ophthalmic Viscosurgical Devices (OVDs) play a crucial role in ophthalmology, primarily used during cataract and other intraocular surgeries to maintain anterior chamber depth, protect corneal endothelial cells, and stabilize the vitreous face. With the increasing prevalence of cataract and related ophthalmic conditions due to an aging global population, the necessity for OVDs is growing. These devices find application in facilitating surgical procedures and ensuring precision and safety while minimizing post-operative complications. The end-use scope encompasses hospitals, ophthalmic clinics, and ambulatory surgical centers, which are increasingly opting for advanced surgical techniques and devices. Market growth is influenced by factors such as the rising demand for minimally invasive surgeries, technological advancements in ophthalmic products, and an increasing number of optometrists and ophthalmologists in developing regions. Furthermore, government support and healthcare insurance have enabled wider accessibility and affordability of eye care services, boosting market prospects. Emerging opportunities lie in the untapped markets of the Asia-Pacific and Latin America regions, where increasing healthcare investments and awareness campaigns about ocular health are underway. Companies could benefit by expanding their distribution networks and partnering with local health organizations to capture a significant market share. However, the market faces limitations such as the high cost of surgical procedures and devices, stringent regulatory approvals, and potential complications arising from improper use of OVDs. Innovation could focus on developing cost-effective, biodegradable, and bio-compatible OVDs, enhancing patient outcomes and device efficacy. Moreover, research on personalized medicine and the integration of digital health technologies could unlock new avenues for growth. The market is characterized by intense competition, with key players focusing on strategic mergers and acquisitions, product innovations, and regional expansions to maintain their foothold. Thus, businesses must emphasize strategic partnerships, R&D investment, and technological advancements to thrive in this evolving landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 648.33 million
Estimated Year [2024] USD 702.86 million
Forecast Year [2030] USD 1,171.29 million
CAGR (%) 8.81%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Ophthalmic Viscosurgical Devices Market

The Ophthalmic Viscosurgical Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising Cases of the Ophthalmic and Ocular Disorders
    • Availability of Well-Equipped Healthcare Infrastructure and Increasing Number of Drugs Approvals
  • Market Restraints
    • Availability of Minimally Invasive and Non-Invasive Treatment Options
  • Market Opportunities
    • Introduction of New Types of Ophthalmic Viscosurgical Devices
    • Ongoing Clinical Consideration of Adhesive for Ophthalmic Viscosurgeries
  • Market Challenges
    • Limited Availability of Skilled Professionals for Ophthalmic Procedures

Porter's Five Forces: A Strategic Tool for Navigating the Ophthalmic Viscosurgical Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Ophthalmic Viscosurgical Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Ophthalmic Viscosurgical Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Ophthalmic Viscosurgical Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Ophthalmic Viscosurgical Devices Market

A detailed market share analysis in the Ophthalmic Viscosurgical Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Ophthalmic Viscosurgical Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Ophthalmic Viscosurgical Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Ophthalmic Viscosurgical Devices Market, highlighting leading vendors and their innovative profiles. These include Bausch & Lomb Incorporated, Amring Pharmaceuticals Inc., Advin Health Care, SERVImed Industrial S.p.A., Rayner Group, Johnson & Johnson Services, Inc., Lifecore Biomedical, Inc., Bohus BioTech AB, Ophtechnics Unlimited, Fidia Farmaceutici S.p.A., Alcon Inc., Precision Lens, Truviz Ophthalmic, Ildong Hyaltech Co., Ltd., Bloomage Biotechnology Corporation Limited, Henan Universe Intraocular Lens Research and Manufacture Co., Ltd., ALBOMED GmbH, LG Chem Life Sciences, Beaver-Visitec International, Inc., Kewpie Corporation, CIMA Technology, Inc., Carl Zeiss AG, Advanced BioMatrix, Maxigen Biotech Inc., and Contipro a.s..

Market Segmentation & Coverage

This research report categorizes the Ophthalmic Viscosurgical Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Cohesive, Combined, and Dispersive.
  • Based on Application, market is studied across Cataract Surgery, Glaucoma Surgery, and Keratoplasty.
  • Based on End User, market is studied across Ambulatory Surgical Center, Eye Specialty Clinics, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising Cases of the Ophthalmic and Ocular Disorders
      • 5.1.1.2. Availability of Well-Equipped Healthcare Infrastructure and Increasing Number of Drugs Approvals
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of Minimally Invasive and Non-Invasive Treatment Options
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of New Types of Ophthalmic Viscosurgical Devices
      • 5.1.3.2. Ongoing Clinical Consideration of Adhesive for Ophthalmic Viscosurgeries
    • 5.1.4. Challenges
      • 5.1.4.1. Limited Availability of Skilled Professionals for Ophthalmic Procedures
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing popularity of cohesive and dispersive OVDs due to their versatility and surgical safety
    • 5.2.2. Application: Increasing uses of OVDs in cataract and keratoplasty surgeries offering clear visualizations while ensuring patient's safety
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization

6. Ophthalmic Viscosurgical Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Cohesive
  • 6.3. Combined
  • 6.4. Dispersive

7. Ophthalmic Viscosurgical Devices Market, by Application

  • 7.1. Introduction
  • 7.2. Cataract Surgery
  • 7.3. Glaucoma Surgery
  • 7.4. Keratoplasty

8. Ophthalmic Viscosurgical Devices Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Center
  • 8.3. Eye Specialty Clinics
  • 8.4. Hospitals

9. Americas Ophthalmic Viscosurgical Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Ophthalmic Viscosurgical Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Ophthalmic Viscosurgical Devices Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Coherus is Selling Off Its Ophthalmology Franchise to Sandoz
    • 12.3.2. Rayner Announces Acquisition of Sophi
    • 12.3.3. Bausch + Lomb Launches New Ophthalmic Viscosurgical Devices in the United States

Companies Mentioned

  • 1. Bausch & Lomb Incorporated
  • 2. Amring Pharmaceuticals Inc.
  • 3. Advin Health Care
  • 4. SERVImed Industrial S.p.A.
  • 5. Rayner Group
  • 6. Johnson & Johnson Services, Inc.
  • 7. Lifecore Biomedical, Inc.
  • 8. Bohus BioTech AB
  • 9. Ophtechnics Unlimited
  • 10. Fidia Farmaceutici S.p.A.
  • 11. Alcon Inc.
  • 12. Precision Lens
  • 13. Truviz Ophthalmic
  • 14. Ildong Hyaltech Co., Ltd.
  • 15. Bloomage Biotechnology Corporation Limited
  • 16. Henan Universe Intraocular Lens Research and Manufacture Co., Ltd.
  • 17. ALBOMED GmbH
  • 18. LG Chem Life Sciences
  • 19. Beaver-Visitec International, Inc.
  • 20. Kewpie Corporation
  • 21. CIMA Technology, Inc.
  • 22. Carl Zeiss AG
  • 23. Advanced BioMatrix
  • 24. Maxigen Biotech Inc.
  • 25. Contipro a.s.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦